A Retrospective Cohort Analysis of SMARCA4-Deficient Lung Cancer
Sponsored by Shanghai Pulmonary Hospital, Shanghai, China
About this trial
Last updated 10 months ago
Study ID
L23(357)
Status
Completed
Type
Observational
Placebo
No
Accepting
All Ages
All Sexes
Trial Timing
Ended a year ago
What is this trial about?
This is a single-center retrospective analysis to explore the clinical characteristics, therapeutic efficacy, and tumor immune microenvironment of SMARCA4-deficient advanced non-small-cell lung cancer (NSCLC).
What are the participation requirements?
Inclusion Criteria
* Diagnosed with stage III-IV NSCLC according to the American Joint Committee on Cancer staging criteria (7th edition);
* Lesions are measurable according to the Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1;
* Receiving first-line immunotherapy or chemotherapy as anti-tumor treatment.
Exclusion Criteria
* SMARCA4 gene test was not performed;
* Not receive treatment;
* Lost to follow-up after one treatment cycle.